QIASTAT-DX
LIVE

Serial Number

88030446

Owner

QIAGEN GMBH

Attorney

Daniel M. Gurfinkel

Filing Date

Jul 9, 2018

Add to watchlist:

No watchlists yet
View on USPTO

QIASTAT-DX Trademark

Serial Number: 88030446 • Registration: 5761187

QIASTAT-DX is a trademark filed by QIAGEN GMBH on July 9, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

July 9, 2018

Registration Date

May 28, 2019

Published for Opposition

March 12, 2019

Goods & Services

Single-use cartridges for clinical laboratory use containing nucleic acid extraction column and/or real time Polymerase Chain Reaction chambers

Diagnostic preparations for medical or veterinary purposes; diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; cartridges sold pre-filled with reagents and/or liquids for medical and medical diagnostic use; cartridges sold pre-filled with reagents for sample preparation and analysis for medical or veterinary diagnostic use; Single-use cartridges for medical diagnostic purposes, containing reagents and/or liquids for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers; cartridges sold pre-filled with reagents for breaking of cell material, nucleic acid purification, amplification and hybridization for medical or medical diagnostic use

Chemical, biochemical and biotechnological reagents for industrial and scientific purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use; Chemical reagents for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances

Medical diagnostic apparatus and instruments for use in preparing blood, bodily fluid and human biological samples for further testing and for the detection and identification of pathogen nucleic acids in blood, bodily fluids and biological samples; Analyzers for medical use for analyzing blood, bodily fluids and human biological samples; Analyzers for medical diagnosis for analyzing blood, bodily fluids and human biological samples; Medical and clinical diagnosis apparatus and machines, namely, molecular and immunoassay analyzers for analyzing blood and bodily fluids; Testing instruments for medical diagnostic purposes, namely, analyzers for detection and identification of pathogen nucleic acids in blood, bodily fluids and human biological samples; Apparatus for carrying-out diagnostic tests for medical purposes for testing blood bodily fluids and human biological samples

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 2, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 2, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 2, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 25, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 28, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
May 28, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 20, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 5, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 5, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 5, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 5, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 30, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 22, 2019 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 9, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 7, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 7, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 7, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2019 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 31, 2018 GPRN
PRIORITY ACTION E-MAILED
Oct 31, 2018 GPRA
PRIORITY ACTION WRITTEN
Oct 31, 2018 CPRA
ASSIGNED TO EXAMINER
Oct 26, 2018 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 11, 2018 AMPX
ASSIGNED TO LIE
Sep 6, 2018 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 23, 2018 PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 23, 2018 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2018 NWOS
NEW APPLICATION ENTERED
Jul 12, 2018 NWAP